Active substance: Risendronic Acid

Form: Cps

Dosage/Packaging:
35mg
4 Cps 35mg

Shelf life: 36 months

Indications:
Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of postmenopausal osteoporosis manifested to reduce the risk of hip fractures. Treatment of osteoporosis in men at high risk of fractures.